These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7308272)

  • 1. Radioimmunoassay of plasma lisuride in man following intravenous and oral administration of lisuride hydrogen maleate: effect on plasma prolactin level.
    Hümpel M; Nieuweboer B; Hasan SH; Wendt H
    Eur J Clin Pharmacol; 1981; 20(1):47-51. PubMed ID: 7308272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics and pharmacodynamics of lisuride in healthy volunteers after intravenous, intramuscular, and subcutaneous injection.
    Krause W; Mager T; Kühne G; Duka T; Voet B
    Eur J Clin Pharmacol; 1991; 40(4):399-403. PubMed ID: 2050175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics in man of the dopamine antagonist ergot derivative, bromerguride.
    Krause W; Sauerbrey N; Gräf KJ
    Eur J Clin Pharmacol; 1986; 31(2):165-8. PubMed ID: 3803415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin-lowering effect of low doses of lisuride in man.
    Horowski R; Wendt H; Gräf KJ
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):234-40. PubMed ID: 415471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics and biotransformation of 14C-lisuride hydrogen maleate in rhesus monkey and in man.
    Hümpel M; Krause W; Hoyer GA; Wendt H; Pommerenke G
    Eur J Drug Metab Pharmacokinet; 1984; 9(4):347-57. PubMed ID: 6532807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of the ergot derivative, transdihydrolisuride, in man.
    Krause W; Dorow R; Nieuweboer B; Hasan SH
    Eur J Clin Pharmacol; 1984; 27(3):335-9. PubMed ID: 6510462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of lisuride hydrogen maleate in the hyperprolactinaemia-amenorrhoea syndrome: clinical and hormonal responses.
    De Cecco L; Foglia G; Ragni N; Rossato P; Venturini PL
    Clin Endocrinol (Oxf); 1978 Dec; 9(6):491-8. PubMed ID: 106990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of lisuride after subcutaneous infusion.
    Krause W; Nieuweboer B; Ruggieri S; Stocchi F; Suchy I
    J Neural Transm Suppl; 1988; 27():71-4. PubMed ID: 3165439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Lisuride on serum prolactin levels during puerperium.
    Venturini PL; Maganza C; Massimilla A; Campanella P; Rossato P; Ragni N; De Cecco L
    Acta Eur Fertil; 1979 Jun; 10(2):51-5. PubMed ID: 545976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and endocrine effects of terguride in healthy subjects.
    Krause W; Träger H; Kühne G; Sauerbrey N; Gräf KJ; Dorow R
    Eur J Clin Pharmacol; 1990; 38(6):609-15. PubMed ID: 2373136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lisuride hydrogen maleate: evidence for a long lasting dopaminergic activity in humans.
    Liuzzi A; Chiodini PG; Oppizzi G; Botalla L; Verde G; De Stefano L; Colussi G; Gräf KJ; Horowski R
    J Clin Endocrinol Metab; 1978 Feb; 46(2):196-202. PubMed ID: 108287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of prolactin secretion by lisuride throughout the menstrual cycle and in hyperprolactinaemic menstrual disorders.
    Bohnet HG; Hanker JP; Horowski R; Wickings EJ; Schneider HP
    Acta Endocrinol (Copenh); 1979 Sep; 92(1):8-19. PubMed ID: 386688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of oral terguride in patients with a prolactinoma.
    Lapka R; Marek J; Rejholec V; Franc Z
    Eur J Clin Pharmacol; 1986; 30(3):363-5. PubMed ID: 3732377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lactation inhibition with various dosages of lisuride--prolactin secretion and effectiveness].
    Strahl HJ; Göretzlehner G; Strahl S; Kunkel S
    Zentralbl Gynakol; 1985; 107(5):300-3. PubMed ID: 4039514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of terguride following intramuscular administration in cows and goats.
    Lapka R; Krejci P; Lidický J; Frühaufová M; Rezábek K
    Acta Physiol Pol; 1989; 40(1):139-44. PubMed ID: 2603744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of lisuride hydrogen maleate, an ergot derivative on anterior pituitary hormone secretion in man.
    Delitala G; Wass JA; Stubbs WA; Jones A; Williams S; Besser GM
    Clin Endocrinol (Oxf); 1979 Jul; 11(1):1-9. PubMed ID: 117952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lisuride in parkinsonism.
    Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A
    Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of lisuride hydrogen maleate in rat, rabbit and rhesus monkey.
    Humpel M; Toda T; Oshino N; Pommerenke G
    Eur J Drug Metab Pharmacokinet; 1981; 6(3):207-19. PubMed ID: 7308240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the effects of lisuride and pimozide on the preovulatory surge of FSH, LH and prolactin in rat.
    Kun I; Simionescu L; Oprescu M; Zamfir-Grigorescu D
    Endocrinologie; 1984; 22(3):177-82. PubMed ID: 6436960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.